Journals / MN Kardiyoloji / 2018 / Cilt: 25 - Sayı: 4

Does the Success of Percutaneous Mitral Balloon Valvuloplasty Differ Among Genders? Single-Center Experience

Perkütan Mitral Balon Valvüloplasti Başarısı Cinsiyete Göre Farklılık Gösterir mi? Tek Merkez Tecrübesi

Pages
166–171
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, in long-term follow-up, there might be a difference between genders regarding the need for mitral valve surgery that all patients who underwent mitral valve surgery were female.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Percutaneous mitral balloon valvuloplasty is the preferred treatment for the patients with symptomatic mitral stenosis.
📊
Key Findings & Data:It has been reported that gender is a significant predictor in most of the applied therapies regarding both short-term and long-term outcomes in cardiovascular diseases.
💡
Conclusion & Impact:However, in long-term follow-up, there might be a difference between genders regarding the need for mitral valve surgery that all patients who underwent mitral valve surgery were female.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Percutaneous mitral balloon valvuloplasty is the preferred treatment for the patients with symptomatic mitral stenosis. It has been reported that gender is a significant predictor in most of the applied therapies regarding both short-term and long-term outcomes in cardiovascular diseases. Therefore, we aimed to assess gender-related differences in patients with MS treated with percutaneous mi- tral balloon valvuloplasty. Mterial and method: In this retrospective study, a total of 148 patients (mean age 42.9±11.1 years, 14.1% male) with mitral stenosis who had favorable valve morphology and underwent percutaneous mitral balloon valvuloplasty were enrolled. Results: All of the patients were followed for a mean follow-up period of 43.3±13.4 months. Procedural success was achieved in 123 (83.1%) patients. At multivariate analysis, only valvular calcification was found related to successful percutaneous mitral balloon valvu- loplasty (Odds ratio: 0.172, Confidence interval: 0.049-0.600, p=0.006). During long-term follow-up, 18 (12.1%) patients underwent mi- tral valve surgery, and all of them were female. At multivariate analysis, mitral valve area after percutaneous mitral balloon valvulo- plasty and presence of atrial fibrillation were found independent predictors of need for mitral valve surgery. Also, there was no signifi- cant difference between genders regarding major adverse cardiac event-free survival (p=0.074). Conclusions: Procedural success did not differ among genders. However, in long-term follow-up, there might be a difference between genders regarding the need for mitral valve surgery that all patients who underwent mitral valve surgery were female.

Özet

Amaç: Perkütan mitral balon valvüloplasti semptomatik mitral darlığı olan hastalarda tercih edilen bir tedavi yöntemidir. Daha önce cin- siyetin kalp hastalıklarında uygulanan tedavilerde kısa ve uzun dönem sonuçlarla ilişkisi bildirilmiştir. Bu sebepten, mitral darlığı olan ve perkütan mitral balon valvüloplasti uygulanan hastalarda cinsiyetle ilişkili farkılıkları araştırdık. Gereç ve yöntem: Bu geriye dönük çalışmaya perkütan mitral balon valvüloplasti için uygun kapak yapısına sahip ve işlem uygulanan toplamda 148 hasta (ortalama yaş 42,9±11,1 yıl, %14,1 erkek) dahil edildi. Bulgular: Bütün hastalar ortalama 43,3±13,4 ay takip edildi. 123 (%83,1) hastada perkütan mitral balon valvüloplasti işlemi başarılı ol- du. Çok değişkenli olasılık oranı analizinde, sadece kapak kalsifikasyonu işlem başarısıyla ilişkili bulundu (Odds oranı: 0,172, Güven ara- lığı: 0,049-0,600, p=0,006). Uzun dönemde, 18 hastaya (%12,1) metalik kapak değişimi uygulandı ve bunların hepsinin cinsiyeti kadın- dı. Metalik kapak değişimine gitmedeki faktörleri belirlemek için yapılan çok değişkenli olasılık oranı analizinde, perkütan mitral balon valvüloplasti sonrası mitral kapak alanı ve atriyal fibrilasyon varlığı bağımsız belirteç olarak bulundu. Ayrıca, olaysız sağ kalım açısından cinsiyetler arası farklılık gözlemlenmedi (p=0,074). Sonuç: İşlem başarısı cinsiyete göre farklılık göstermemiştir. Fakat, uzun dönem takipte metalik kapak değişimi uygulanan bütün hasta- ların kadın olduğu düşünülürse, kadın cinsiyet aleyhine bir farklılık olabilir.

🔖

Cite This Article

MADEN, O., BALCI, K. G., KUYUMCU, M. S., BALCI, M. M., SELÇUK, H., SELÇUK, M. T., TÜFEKÇİOĞLU, O. (2018). Does the Success of Percutaneous Mitral Balloon Valvuloplasty Differ Among Genders? Single-Center Experience. MN Kardiyoloji, Cilt: 25 - Sayı: 4, 166–171. https://ajindex.com/articles/297245

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5(11): 685-94.
  2. Ray R, Chambers J. Mitral valve disease. Int J Clin Pract 2014;68(10):1216-20.
  3. Masjedi S, Ferdous Z. Understanding the Role of Sex in Heart Valve and Major Vascular Diseases. Cardiovasc Eng Technol 2015;6(3):209-19.
  4. Zühlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J 2015;36 (18):1115-22a. Kazemi B, Rostami A, Aslanabadi N, Ghaffari S. Electro - cardiographic P-wave Indices as a Useful Tool to Predict Successful Percutaneous Balloon Mitral Valvotomy in Patients with Mitral Stenosis. J Cardiovasc Thorac Res 2014;6(1):9-14.
  5. Bitigen A, Türkmen M, Karakaya O, et al. Early effects of percutaneous mitral valvuloplasty on left atrial mechanical functions. Tohoku J Exp Med 2006;209(4):285-9.
  6. Chandrasekhar J, Baber U, Sartori S, et al. Sex-related dif- ferences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS Study. Catheter Cardiovasc Interv 2017;89 (4):629-37.
  7. Xu YZ, Friedman PA, Webster T, et al. Cardiac resynchro- nization therapy: do women benefit more than men? J Cardiovasc Electrophysiol 2012;23(2):172-8.
  8. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2197-223.
  9. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: in- cidence and progression in the northern territory of Australia, 1997 to 2010. Circulation 2013;128(5):492-501.
  10. Bouleti C, Iung B, Laouénan C, et al. Late results of percu- taneous mitral commissurotomy up to 20 years: develop- ment and validation of a risk score predicting late func- tional results from a series of 912 patients. Circulation 2012;125(17):2119-27.
  11. Tomai F, Gaspardone A, Versaci F, et al. Twenty year follow- up after successful percutaneous balloon mitral valvulo- plasty in a large contemporary series of patients with mi- tral stenosis. Int J Cardiol 2014;177(3):881-5.
  12. Chen CR, Cheng TO. Percutaneous balloon mitral valvulo- plasty by the Inoue technique: a multicenter study of 4832 patients in Chi